A Pilot Study on Diurnal Variation

Interested in this Trial?

Contact Us

Trial Status Terminated

Trial Identifier

NCT01806051

Condition

Phenylketonuria, Phenylketonuria (PKU)

The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.

Trial Summary

This self-controlled, prospective, pilot study is designed to gather information regarding the diurnal variation (changes that occur each day) in the levels of plasma phenylalanine (Phe) and tyrosine in patients with phenylketonuria (PKU) and in the non-PKU population.

Eligibility Criteria

Birth Sex

All

Age

From 4 Years

Healthy Volunteers

Yes

Drug/Treatment:

Kuvan

Phase:

Na

Study Type:

Interventional

Number of Participants:

6

Study Started:

2013-03

Study Updated:

2016-04-20

Trial Locations

  • Children's Hospital Los Angeles

    Los Angeles, California, United States

Inclusion Criteria

PKU PARTICIPANTS (ARM 1):

  • Subject has a confirmed diagnosis of PKU with hyperphenylalaninemia documented by a fasting Phenylalanine level of at least 360 umol/L (6 mg/dL)
  • Patient is at least 4 years old (there is no upper age limit for this study)
  • Willing and able to provide written authorization or, if under the age of 18 years, provide written assent (if required) and written patient authorization by a parent or legal guardian
  • Willing to undergo study related procedures including commencing Kuvan treatment for patient not currently on treatment; temporary discontinuation of Kuvan for patient on treatment; and completing the 24-Hour Blood Assessment
  • Authorized to provide personal health information
  • Subjects should not be pregnant and willing to use appropriate birth control during the study

CONTROL GROUP (ARM 2):

  • Healthy, non-PKU individuals. They will be age-sex matched to the PKU group. They may be a relative (ex: sibling) of a PKU participant, but they don’t have to be a blood relation.
  • Individual is at least 4 years old (there is no upper age limit)
  • Willing and able to provide written consent or, if under the age of 18 years, provide written assent and written participant authorization by a parent or legal guardian
  • Authorized to provide personal health information

Exclusion Criteria

Exclusion Criteria (BOTH ARMS):

  • Subjects who do not meet all the inclusion criteria
  • Age < 4 years
  • Concomitant medical problems or medications which at the discretion of the principal investigator would put participant at health risk or prevent them from completing study.
  • If female, unwillingness to use birth control during the period of the study drug administration (this doesn’t apply to Arm 2

Contact BioMarin Clinical Trials

Please complete and submit the following form to express interest in participating and request more information about one of our clinical trials.

By completing this form and clicking the send button, you understand and hereby consent to storage of your personal information, including within the United States and Europe, which will be accessible by BioMarin for purposes such as responding to your request, quality control, fulfilling compliance obligations, and assisting with products, services, or clinical trials. Depending on where you live, you may have the right to request access to, removal, or correction of your personal information held by BioMarin. You may submit your request via the contact information and/or webform located within the full BioMarin Privacy Policy.

*required fields

"*" indicates required fields

This field is hidden when viewing the form
This field is hidden when viewing the form